The value of adenosin-deaminase in etiologic diagnosis of pleural effusions

I. Strambu, M. Ciontu, A. Serbescu, C. Toader, I. P. Stoicescu (Bucharest, Romania)

Source: Annual Congress 2002 - Diagnosis of tuberculosis
Session: Diagnosis of tuberculosis
Session type: Thematic Poster Session
Number: 1065
Disease area: Respiratory infections

Congress or journal article abstract

Abstract

Aim: estimating the importance of measuring adenosin-deaminase (ADA) in pleural fluid for the etiologic diagnosis of pleural effusions. Method: the study included 192 patients admitted for pleurisy for 9 months. Among them, 63 had TB pleurisy, 73 neoplasia, 14 empyema, 18 transudates, 8 para-pneumonic pleurisy, 3 other causes, 7 unknown cause. Diagnosis was confirmed on pleural fluid analysis, sputum and pleural fluid bacteriology and pleural needle biopsy. ADA in pleural fluid was determined by Giusti indirect colorimetric method. Results: the cause of pleurisy was confirmed in 72% of cases. TB was confirmed in 62% and neoplasia in 77%. Mean values of ADA related to diagnosis were: higher in TB (58.4 U/l) and empyema (151.8 U/l) than in nonTB pleurisies (neoplasia - 22.9 U/l, transudates 16.7 U/l). At a threshold value of 50 U/l, the ADA sensibility (Sb) for TB diagnosis was 58.7%, lower than for nonTB cases (neoplasia-86.3%, empyema - 85.7%, parapneumonic - 75%). Specificity (Sp) was 78.9% in TB, neoplasia - 46.2%, parapneumonic - 13.08%, empyema - 86.06%. Positive predictive value (PPV) was 58.7% for TB, 49.6% for neoplasia and 42.8% for empyema. Negative predictive value (NPV) was 79.5% for TB, 84.6% for neoplasia, 98% for empyema. Conclusion: a threshold value of 40u/ml increases significantly the Sb to 71.4% for Tb pleurisy and 78.08% for neoplasia, maintaining an acceptable value of Sp (70.7% for TB, 58% neoplasia), PPV (55.5% TB, 54.8% neoplasia) and NPV (82.7% TB and 80.24% neoplasia). Measuring ADA in pleural fluid, associated to the other investigations, is a supplemental diagnostic tool with remarcable Sb and Sp.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Strambu, M. Ciontu, A. Serbescu, C. Toader, I. P. Stoicescu (Bucharest, Romania). The value of adenosin-deaminase in etiologic diagnosis of pleural effusions. Eur Respir J 2002; 20: Suppl. 38, 1065

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is ²blind² pleural biopsy still of value in tuberculous effusions?
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008

The new method for diagnosis of pleural effusion of unknown etiology
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I
Year: 2008


The diagnostic value of CA-125 in pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 386s
Year: 2001

The value of thoracoscopy in malignant pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 516s
Year: 2001

Diagnostic value of closed pleural needle biopsy for the diagnosis of malignant and tuberculous pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 446s
Year: 2005

Can VEGF be used in differential diagnosis of pleural effusions?
Source: Eur Respir J 2007; 30: Suppl. 51, 565s
Year: 2007

The Abrams pleural biopsy is still useful in the diagnosis of pleural effusions
Source: Annual Congress 2009 - Pleural diseases
Year: 2009


Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006

The value of closed pleural needle biopsy for the diagnosis of pleural effusions of unknown origin
Source: Eur Respir J 2004; 24: Suppl. 48, 71s
Year: 2004

The role of thoracoscopy in the diagnosis of malignant pleural effusions (PE)
Source: Eur Respir J 2002; 20: Suppl. 38, 438s
Year: 2002

Malignant pleural effusions: diagnosis and management
Source: International Congress 2017 – PG5 Pleural disease management
Year: 2017


Malignant pleural effusions: from the diagnosis to the management
Source: International Congress 2015 – ME2 Malignant pleural effusions: from diagnosis to management
Year: 2015




The diagnostic value of the total adenosine deaminase(ADAp) and ADA1/ADAp ratio in the diagnosis of tuberculous pleural effusions
Source: Eur Respir J 2002; 20: Suppl. 38, 168s
Year: 2002

Utility of closed pleural biopsy in the diagnosis of pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 611s
Year: 2006

Diagnostic value of combined assays in differentiating tuberculous and malignant pleural effusions
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


Diagnostic value of leptin in tuberculous pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 426s
Year: 2004

Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion?
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017


Procalcitonin in pleural fluid: A new tool for the diagnosis of empyema and parapneumonic pleural effusions?
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011